TY - JOUR
KW - Anxiety Disorders/diagnosis/psychology/therapy
KW - Cognitive Therapy
KW - Comorbidity
KW - Cost of Illness
KW - Depression/psychology
KW - Feasibility Studies
KW - Humans
KW - Internet
KW - Primary Health Care
KW - Quality of Life
KW - Research Design
KW - Self Report
KW - Sweden
KW - Therapy, Computer-Assisted
KW - Time Factors
KW - Treatment Outcome
AU - L. B. Nordgren
AU - G. Andersson
AU - A. Kadowaki
AU - P. Carlbring
A1 - 
AB - BACKGROUND: Internet-administered cognitive behavioural therapy (ICBT) has been found to be effective for a range of anxiety disorders. However, most studies have focused on one specific primary diagnosis and co-morbidity has not been considered. In primary care settings, patients with anxiety often suffer from more than one psychiatric condition, making it difficult to disseminate ICBT for specific conditions. The aim of this study will be to investigate if ICBT tailored according to symptom profile can be a feasible treatment for primary care patients with anxiety disorders. It is a randomised controlled trial aimed to evaluate the treatment against an active control group. METHODS: Participants with anxiety disorders and co-morbid conditions (N = 128), will be recruited from a primary care population. The Clinical Outcome in Routine Evaluation (CORE-OM) will serve as the primary outcome measure. Secondary measures include self-reported depression, anxiety, quality of life and loss of production and the use of health care. All assessments will be collected via the Internet and measure points will be baseline, post treatment and 12 months post treatment. DISCUSSION: This trial will add to the body of knowledge on the effectiveness of ICBT for anxiety disorders in primary care. The trial will also add knowledge on the long term effects of ICBT when delivered for regular clinic patients TRIAL REGISTRATION: ClinicalTrials.gov: NCT01390168.
BT - Trials
C5 - HIT & Telehealth
CY - England
DO - 10.1186/1745-6215-13-16
JF - Trials
N2 - BACKGROUND: Internet-administered cognitive behavioural therapy (ICBT) has been found to be effective for a range of anxiety disorders. However, most studies have focused on one specific primary diagnosis and co-morbidity has not been considered. In primary care settings, patients with anxiety often suffer from more than one psychiatric condition, making it difficult to disseminate ICBT for specific conditions. The aim of this study will be to investigate if ICBT tailored according to symptom profile can be a feasible treatment for primary care patients with anxiety disorders. It is a randomised controlled trial aimed to evaluate the treatment against an active control group. METHODS: Participants with anxiety disorders and co-morbid conditions (N = 128), will be recruited from a primary care population. The Clinical Outcome in Routine Evaluation (CORE-OM) will serve as the primary outcome measure. Secondary measures include self-reported depression, anxiety, quality of life and loss of production and the use of health care. All assessments will be collected via the Internet and measure points will be baseline, post treatment and 12 months post treatment. DISCUSSION: This trial will add to the body of knowledge on the effectiveness of ICBT for anxiety disorders in primary care. The trial will also add knowledge on the long term effects of ICBT when delivered for regular clinic patients TRIAL REGISTRATION: ClinicalTrials.gov: NCT01390168.
PP - England
PY - 2012
SN - 1745-6215; 1745-6215
SP - 16
T1 - Tailored internet-administered treatment of anxiety disorders for primary care patients: study protocol for a randomised controlled trial
T2 - Trials
TI - Tailored internet-administered treatment of anxiety disorders for primary care patients: study protocol for a randomised controlled trial
U1 - HIT & Telehealth
U2 - 22321916
U3 - 10.1186/1745-6215-13-16
VL - 13
VO - 1745-6215; 1745-6215
Y1 - 2012
ER -